IBRC Community Update: New web design, a documentary, and new members welcome!

The IBRC portal is inspired by the global antibiotic resistance situation & the promising potential phages offer as credible antimicrobial therapeutics.

Launched in October 2018, IBRC is a joint effort by Acharya Narendra Dev College (ANDC), University of Delhi, India and Open Health Systems Laboratory (OHSL), USA to build a consortium of scientists working on phages and lysins.

If you're a phage scientist/scholar, a medical or industry professional, or a phage therapy supporter interested in joining the consortium, contact Dr. Urmi Bajpai at urmibajpai@andc.du.ac.in or at ibrc.pt2018@gmail.com, or tweet @phageconsortium.

To help promote AMR awareness, and prior to launching the IBRC, Dr. Bajpai created a short docu-drama film on AMR and phage therapy (10 min), which will be soon dubbed in other languages too. In it, you'll hear from Pranav Johri of Vitalis Phage Therapy and Mzia Kutateladze, the director of Eliava Institute.